Abstract:Protein nanocages are highly ordered nanometer scale architectures, which are typically formed by homo- or hetero-self-assembly of multiple monomers into symmetric structures of different size and shape. The intrinsic characteristics of protein nanocages make them very attractive and promising as a biological nanomaterial. These include, among others, a high surface/volume ratio, multi-functionality, ease to modify or manipulate genetically or chemically, high stability, mono-dispersity, and biocompatibility. Since the beginning of the investigation into protein nanocages, several applications were conceived in a variety of areas such as drug delivery, vaccine development, bioimaging, biomineralization, nanomaterial synthesis and biocatalysis. The ability to generate large amounts of pure and well-folded protein assemblies is one of the keys to transform nanocages into clinically valuable products and move biomedical applications forward. This calls for the development of more efficient biomanufacturing processes and for the setting up of analytical techniques adequate for the quality control and characterization of the biological function and structure of nanocages. This review concisely covers and overviews the progress made since the emergence of protein nanocages as a new, next-generation class of biologics. A brief outline of non-viral protein nanocages is followed by a presentation of their main applications in the areas of bioengineering, biotechnology, and biomedicine. Afterwards, we focus on a description of the current processes used in the manufacturing of protein nanocages with particular emphasis on the most relevant aspects of production and purification. The state-of-the-art on current characterization techniques is then described and future alternative or complementary approaches in development are also discussed. Finally, a critical analysis of the limitations and drawbacks of the current manufacturing strategies is presented, alongside with the identification of the major challenges and bottlenecks.

Assembly of Protein Cages for Drug Delivery

Protein nanocage architectures for the delivery of therapeutic proteins

Protein Nanoparticles Directed Cancer Imaging and Therapy

Emerging prospects of protein/peptide-based nanoassemblies for drug delivery and vaccine development

Protein Nanoparticles: Promising Platforms for Drug Delivery Applications

Protein-Based Nanoparticles as Drug Delivery Systems

Nanocarriers for intracellular delivery of proteins in biomedical applications: strategies and recent advances

Self-assembled polymer nanostructures for delivery of anticancer therapeutics

Efficient Delivery of Cytosolic Proteins by Protein-Hexahistidine-Metal Co-Assemblies

Synthesis of protein nanoparticles for drug delivery

Protein-nanoparticle co-assembly supraparticles for drug delivery: Ultrahigh drug loading and colloidal stability, and instant and complete lysosomal drug release

Protein Cage Directed Assembly of Binary Nanoparticle Superlattices

Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs

Protein‐Based Encapsulation Strategies: Toward Micro‐ and Nanoscale Carriers with Increased Functionality

Synthetic Nanocarriers for Intracellular Protein Delivery

Tailoring nanocarriers for intracellular protein delivery.

Core-Shell Nanoparticles Fabricated By Tri-Capillary Coaxial Electrospray And Template Removal Method For Protein Delivery

Developing Porous Protein Cage Nanoparticles as Cargo-Loadable and Ligand-Displayable Modular Delivery Nanoplatforms

Manufacturing of non-viral protein nanocages for biotechnological and biomedical applications

Macromolecular Cargo Encapsulation via In Vitro Assembly of Two‐Component Protein Nanoparticles

Redesign of protein nanocages: the way from 0D, 1D, 2D to 3D assembly